-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991576
September 09, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991576
September 09, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/download/temp/pdfexport-20230227-270223-2010-505/114990879_9d294603c5734b2f818cd4c67a03c2f4-270223-2010-506.pdf?contentType=application/pdf
January 01, 2010 - emerging standards; scope-adjust high-energy industry activities; address potential conflicts,
overlaps, adverse
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991555
decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991576
decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991534
This has adverse consequences for reporting and research as well as quality improvement or even effectively
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114992864
This has adverse consequences for reporting and research as well as quality improvement or even effectively
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991532
This has adverse consequences for reporting and research as well as quality improvement or even effectively
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114990917
This has adverse consequences for reporting and research as well as quality improvement or even effectively
-
cmext.ahrq.gov/confluence/exportword?pageId=114990917
This has adverse consequences for reporting and research as well as quality improvement or even effectively
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991564
October 05, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991559
October 05, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991555
October 05, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991564
October 05, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991559
October 05, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991555
October 05, 2021 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/exportword?pageId=114990839
January 01, 2019 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991564
decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114992884
January 01, 2006 - decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991559
decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse … decisions are considered (e.g., screening modalities or selection of alternate treatments with different adverse